 |
 |
| Product ID |
Structure |
Product Name |
Purity |
Price |
Delete |
| JR6-L8576 |
 |
2-[5-((2S)pyrrolidin-2-yl)-2-pyridyl]acetic acid |
96%
|
|
Delete |
| AS-5570 |
 |
2-AMINO-THIOBENZAMIDE |
98%
|
|
Delete |
| A1-1117 |
 |
2-Methoxypyrimidine-5-boronic acid |
98%
|
2g/$3505g/$49510g/POA |
Delete |
| JR6-L8095 |
 |
3-((2R)pyrrolidin-2-yl)-5-bromopyridine |
96%
|
|
Delete |
| AS-4724 |
 |
3-Methoxybenzonitrile |
98%
|
|
Delete |
| JR6-L4391 |
 |
3-Pyrrolidinol, 1-(2-pyridinylmethyl)-, (R)- (9CI) |
96%
|
|
Delete |
| A1-1414 |
 |
4-Amino-2,6-dichloropyridine |
|
25g/$250100g/POA |
Delete |
| JR6-L8573 |
 |
5-((2R)pyrrolidin-2-yl)-2,3-difluoropyridine |
96%
|
|
Delete |
| JR6-L5720 |
 |
a-D-Mannopyranoside, 3-butyn-1-yl, 2,3,4,6-tetraacetate |
96%
|
|
Delete |
| JR6-L2216 |
 |
Benzenepropanoic acid, ß-amino-3-fluoro-, 1,1-dimethylethyl ester, (ßR)- |
96%
|
$680/1g, $2980/5g |
Delete |
| JR6-L2222 |
 |
Benzenepropanoic acid, ß-amino-3-methoxy-, 1,1-dimethylethyl ester, (ßS)- |
96%
|
$680/1g, $2980/5g |
Delete |
| JR6-L2062 |
 |
Benzenepropanoic acid, ß-amino-4-(1-methylethyl)-, (ßR)- |
96%
|
$398/1g, $$1280/5g, $4980/25g |
Delete |
| JR6-L3696 |
 |
Benzoic acid, 2-(diphenylphosphino)-4-[19-[(3aS,4S,6aR)-hexahydro-2-oxo-1H-thieno[3,4-d]imidazol-4-yl]-1,15-dioxo-5,8,11-trioxa-2,14-diazanonadec-1-yl]-, methyl ester |
96%
|
|
Delete |
| AS-7843 |
 |
Bismaleimide |
98%
|
|
Delete |
| JR6-L2999 |
 |
Carbamic acid, N-(4-bromo-5-formyl-2-thiazolyl)-, 1,1-dimethylethyl ester |
96%
|
$680/1g, $2980/5g |
Delete |
| AS-7574 |
 |
Ethyl butyrylacetate |
98%
|
|
Delete |
| JR8-N0713 |
 |
Gaultherin |
98%
|
$1000/20mg |
Delete |
| JR8-N0658 |
 |
Isofraxidin |
98%
|
|
Delete |
| A1-1771 |
 |
Methyl 6-chloropyridine-2-carboxylate |
97%
|
10g/$775 |
Delete |
| JR6-L2684 |
 |
Oxirane, 2-[(2-chlorophenoxy)methyl]-, (2S)- |
96%
|
|
Delete |
| AS-5560 |
 |
PIPERONALDOXIME |
98%
|
|
Delete |
| JR6-L2689 |
 |
ß-L-lyxo-Hexofuranose, 5,6-anhydro-3-deoxy-1,2-O-(1-methylethylidene)- |
96%
|
|
Delete |
|
Continue browsing products
Quote/Order
Inquiry
|
|
|
 |
 |
 |